SPDR Series Trust - SPDR S&P Pharmaceuticals ETF reported earnings results for the half year ended December 31, 2023. For the half year, the company reported revenue was USD 1.95 million. Net income was USD 6.17 million.
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF
Equities
XPH
US78464A7220
Investment Trusts
1st Jan change | Capi. | |
---|---|---|
+11.51% | 15.36B | |
+6.65% | 6.56B | |
+18.69% | 4.73B | |
+10.97% | 4.47B | |
-9.50% | 4B | |
+11.33% | 3.42B | |
-2.23% | 3.39B | |
+11.68% | 3.23B | |
-0.21% | 2.88B |